id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-E-2611-0007,FDA,FDA-2023-E-2611,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-09-18T04:00:00Z,2025,9,2025-09-18T04:00:00Z,,2025-09-18T23:01:06Z,,0,0,09000064b8fb0070
FDA-2023-E-2611-0006,FDA,FDA-2023-E-2611,Determination of Regulatory Review Period for Purposes of Patent Extension; AGILI–C,Notice,Determinations,2024-11-19T05:00:00Z,2024,11,2024-11-19T05:00:00Z,2025-01-22T04:59:59Z,2024-11-19T13:37:18Z,2024-26910,0,0,0900006486827d2d
FDA-2023-E-2611-0005,FDA,FDA-2023-E-2611,Letter from FDA CDER to U. S. Patent and Trademark Office,Other,Letter(s),2024-11-04T05:00:00Z,2024,11,2024-11-04T05:00:00Z,,2024-11-04T19:20:46Z,,0,0,09000064867edea3
FDA-2023-E-2611-0004,FDA,FDA-2023-E-2611,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-03-22T04:00:00Z,2024,3,2024-03-22T04:00:00Z,,2024-03-22T13:29:32Z,,0,0,090000648648be68
FDA-2023-E-2611-0003,FDA,FDA-2023-E-2611,Letter from FDA CDER to U S Patent and TradeMark Office,Other,Letter(s),2024-01-19T05:00:00Z,2024,1,2024-01-19T05:00:00Z,,2024-01-19T23:54:48Z,,0,0,09000064863ae057
FDA-2023-E-2611-0002,FDA,FDA-2023-E-2611,"Patent Extension Application from Sterne, Kessler, Goldstein & Fox P.L.L.C. (on behalf of Cartiheal (2009) Ltd.)",Other,Application,2023-06-26T04:00:00Z,2023,6,2023-06-26T04:00:00Z,,2023-06-26T17:45:28Z,,0,0,0900006485bf5140
FDA-2023-E-2611-0001,FDA,FDA-2023-E-2611,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2023-06-26T04:00:00Z,2023,6,2023-06-26T04:00:00Z,,2023-06-26T17:45:22Z,,0,0,0900006485bf513c